Anwar MA, Al Shehabi TS, Eid AH. Inflammogenesis of secondary spinal cord injury. Front Cell Neurosci. 2016;10:98.
Article PubMed PubMed Central Google Scholar
Coleman D. Regulation of macrophage phagocytosis. Eur J Clin Microbiol. 1986;5:1–5.
Article CAS PubMed Google Scholar
Ransohoff RM, Perry VH. Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol. 2009;27:119–45.
Article CAS PubMed Google Scholar
Durafourt BA, Moore CS, Zammit DA, Johnson TA, Zaguia F, Guiot MC, et al. Comparison of polarization properties of human adult microglia and blood-derived macrophages. Glia. 2012;60:717–27.
Benakis C, Garcia-Bonilla L, Iadecola C, Anrather J. The role of microglia and myeloid immune cells in acute cerebral ischemia. Front Cell Neurosci. 2014;8:461.
Cherry JD, Olschowka JA, O’Banion MK. Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J Neuroinflamm. 2014;11:98.
Jurga AM, Paleczna M, Kuter KZ. Overview of general and discriminating markers of differential microglia phenotypes. Front Cell Neurosci. 2020;14:198.
Article PubMed PubMed Central Google Scholar
Samokhvalov IM, Samokhvalova NI, Nishikawa S-I. Cell tracing shows the contribution of the yolk sac to adult haematopoiesis. Nature. 2007;446:1056.
Article CAS PubMed Google Scholar
Kierdorf K, Erny D, Goldmann T, Sander V, Schulz C, Perdiguero EG, et al. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat Neurosci. 2013;16:273–80.
Article CAS PubMed Google Scholar
Galili U. Anti-Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefits. Immunology. 2013;140:1–11.
Article CAS PubMed PubMed Central Google Scholar
Galili U, Clark MR, Shohet SB, Buehler J, Macher BA. Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1–3Gal epitope in primates. Proc Natl Acad Sci U S A. 1987;84:1369–73.
Article CAS PubMed PubMed Central Google Scholar
Galili U, Shohet SB, Kobrin E, Stults CL, Macher BA. Man, apes, and old world monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J Biol Chem. 1988;263:17755–62.
Article CAS PubMed Google Scholar
Galili U, Rachmilewitz EA, Peleg A, Flechner I. A unique natural human IgG antibody with anti-alpha-galactosyl specificity. J Exp Med. 1984;160:1519–31.
Article CAS PubMed Google Scholar
Galili U, Mandrell RE, Hamadeh RM, Shohet SB, Griffiss JM. Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora. Infect Immun. 1988;56:1730–7.
Article CAS PubMed PubMed Central Google Scholar
Galili U, Zhu Z, Chen J, Goldufsky JW, Schaer GL. Near complete repair after myocardial infarction in adult mice by altering the inflammatory response with intramyocardial injection of alpha-Gal nanoparticles. Front Cardiovasc Med. 2021;8:719160.
Article CAS PubMed PubMed Central Google Scholar
Wigglesworth KM, Racki WJ, Mishra R, Szomolanyi-Tsuda E, Greiner DL, Galili U. Rapid recruitment and activation of macrophages by anti-Gal/alpha-Gal liposome interaction accelerates wound healing. J Immunol. 2011;186:4422–32.
Article CAS PubMed Google Scholar
Galili U. Antibody production and tolerance to the alpha-gal epitope as models for understanding and preventing the immune response to incompatible ABO carbohydrate antigens and for alpha-gal therapies. Front Mol Biosci. 2023;10:1209974.
Article CAS PubMed PubMed Central Google Scholar
Galili U. Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol Today. 1993;14:480–2.
Article CAS PubMed Google Scholar
Good AH, Cooper DK, Malcolm AJ, Ippolito RM, Koren E, Neethling FA, et al. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transpl Proc. 1992;24:559–62.
Sandrin MS, Vaughan HA, Dabkowski PL, McKenzie IF. Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1–3)Gal epitopes. Proc Natl Acad Sci U S A. 1993;90:11391–5.
Article CAS PubMed PubMed Central Google Scholar
Collins BH, Cotterell AH, McCurry KR, Alvarado CG, Magee JC, Parker W, et al. Cardiac xenografts between primate species provide evidence for the importance of the alpha-galactosyl determinant in hyperacute rejection. J Immunol. 1995;154:5500–10.
Article CAS PubMed Google Scholar
Galili U, Wigglesworth K, Abdel-Motal UM. Accelerated healing of skin burns by anti-Gal/α-gal liposomes interaction. Burns. 2010;36:239–51.
Galili U. Biosynthesis of alpha-Gal epitopes (Galalpha1-3Galbeta1-4GlcNAc-R) and their unique potential in future alpha-Gal therapies. Front Mol Biosci. 2021;8:746883.
Article CAS PubMed PubMed Central Google Scholar
Vasu S, He S, Cheney C, Gopalakrishnan B, Mani R, Lozanski G, et al. Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blasts. Blood. 2016;127:2879–89.
Article CAS PubMed PubMed Central Google Scholar
Li B, Bedard K, Sorce S, Hinz B, Dubois-Dauphin M, Krause KH. NOX4 expression in human microglia leads to constitutive generation of reactive oxygen species and to constitutive IL-6 expression. J Innate Immun. 2009;1:570–81.
Article CAS PubMed Google Scholar
Gensel JC, Zhang B. Macrophage activation and its role in repair and pathology after spinal cord injury. Brain Res. 2015;1619:1–11.
Article CAS PubMed Google Scholar
Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci. 2009;29:13435–44.
Article CAS PubMed PubMed Central Google Scholar
Gao W, Li JM. Targeted siRNA delivery reduces nitric oxide mediated cell death after spinal cord injury. J Nanobiotechnol. 2017;15:1–11.
Novak ML, Koh TJ. Macrophage phenotypes during tissue repair. J Leukoc Biol. 2013;93:875–81.
Article CAS PubMed PubMed Central Google Scholar
Atri C, Guerfali FZ, Laouini D. Role of human macrophage polarization in inflammation during infectious diseases. Int J Mol Sci. 2018;19:1801.
Article PubMed PubMed Central Google Scholar
Strizova Z, Benesova I, Bartolini R, Novysedlak R, Cecrdlova E, Foley LK, et al. M1/M2 macrophages and their overlaps–myth or reality? Clin Sci. 2023;137:1067–93.
Zivkovic S, Ayazi M, Hammel G, Ren Y. For better or for worse: a look into neutrophils in traumatic spinal cord injury. Front Cell Neurosci. 2021;15:648076.
Article CAS PubMed PubMed Central Google Scholar
Gensel JC, Kopper TJ, Zhang B, Orr MB, Bailey WM. Predictive screening of M1 and M2 macrophages reveals the immunomodulatory effectiveness of post spinal cord injury azithromycin treatment. Sci Rep. 2017;7:40144.
Article CAS PubMed PubMed Central Google Scholar
Shechter R, Miller O, Yovel G, Rosenzweig N, London A, Ruckh J, et al. Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. Immunity. 2013;38:555–69.
Article CAS PubMed PubMed Central Google Scholar
Kong XY, Gao J. Macrophage polarization: a key event in the secondary phase of acute spinal cord injury. J Cell Mol Med. 2017;21:941–54.
Van Broeckhoven J, Erens C, Sommer D, Scheijen E, Sanchez S, Vidal PM, et al. Macrophage-based delivery of interleukin-13 improves functional and histopathological outcomes following spinal cord injury. J Neuroinflammation. 2022;19:102.
Lee SI, Jeong SR, Kang YM, Han DH, Jin BK, Namgung U, et al. Endogenous expression of interleukin-4 regulates macrophage activation and confines cavity formation after traumatic spinal cord injury. J Neurosci Res. 2010;88:2409–19.
留言 (0)